Indicators of altered mitochondrial function in predictive metho

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving oxidoreductase

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 15, 435 14, 435 4, 536 221, C12Q 132, C12Q 148, C12Q 100, C12Q 154

Patent

active

06140067&

ABSTRACT:
The present invention relates to improved diagnostic methods for early detection of a risk for developing type 2 diabetes mellitus in humans, and screening assays for therapeutic agents useful in the treatment of type 2 diabetes mellitus, by comparing the levels of one or more indicators of altered mitochondrial function. Indicators of altered mitochondrial function include enzymes such as mitochondrial enzymes and ATP biosynthesis factors. Other indicators of altered mitochondrial function include mitochondrial mass, mitochondrial number and mitochondrial DNA content, cellular responses to elevated intracellular calcium and to apoptogens, and free radical production. Methods of treating, and of stratifying, human patients as such methods relate to disclosed indicators of altered mitchondrial function are also provided.

REFERENCES:
patent: 5840493 (1998-11-01), Davis et al.
patent: 5888498 (1999-05-01), Davis et al.
Sepehrina et al, Amer. J. Med. Genetics, V. 56(2), p198-202, Mar. 1995.
Anderson, "Mitochondrial Dysfunction in Diabetes Mellitus," Drug Development Research 46:67-79, 1999.
Anderson et al., "Sequence and Organization of the Human Mitochondrial Genome," Nature 290:457-465, 1981.
Antonetti et al., "Increased Expression of Mitochondrial-Encoded Genes in Skeletal Muscle of Humans with Diabetes Mellitus," J. Clin. Invest. 95:1383-1388, 1995.
Baynes, "Role of Oxidative Stress in Development of Complications in Diabetes," Diabetes 40:405-412, 1991.
Baynes and Thorpe, "Role of Oxidative Stress in Diabetic Complications. A New Perspective on an Old Paradigm," Diabetes 48:1-9, 1999.
Belch et al., "Oxidative Stress is Present in Atherosclerotic Peripheral Arterial Disease and Further Increased by Diabetes Mellitus," International Angiology 14(4):385-388, 1995.
Clapham, "Calcium Signaling," Cell 80:259-268, 1995.
Cruz-Orive and Weibel, "Recent Sterological Methods for Cell Biology: A Brief Survey," Am. J. Physiol. 258:L148-L156, 1990.
Davis et al., "Mutations in Mitochondrial Cytochrome c Oxidase Genes Segregrate with Late-Onset Alzheimer Disease," Proc. Natl. Acad. Sci. USA 94:4526-4531, 1997.
Fahy et al., "Multiplex Fluorescene-Based Primer Extension Method for Quantitive Mutation Analysis of Mitochondrial DNA and its Diagnostic Application for Alzheimer's Disease," Nucleic Acids Research 25(15):3102-3109, 1997.
Ghosh et al., "Longitudinal Study of a Heteroplasmic 3460 Leber Hereditary Optic Neuropathy Family by Multiplexed Primer-Extension Analysis and Nucleotide Sequencing," Am. J. Hum. Genet. 58:325-334, 1996.
Gomez-Diaz et al., "Ascorbate Stabilization Is Stimulated in p.degree.HL-60 Cells by CoQ.sub.10 Increase at the Plasma Membrane," Biochemical And Biophysical Research Communications 234:79-81, 1997.
Gross et al., "The Effect of Streptozotocin-Induced Diabetes on Oxidative Phosphorylation and Related Reactions in Skeletal Muscle Mitochondria," Horm. Metab. Res. 4(1-7):1-7, 1972.
Hinokio et al., "Oxidative Damage to Mitochondrial DNA: Its Relationship to Diabetic Complication," Diabetes 46(Supplement 1):173A, Abstract No. 0665, 1997.
Huang et al., "Identification of Differentially Expressed Genes in NIDDM by cDNA Differentially Display," Diabetologia 39(Supplemental 1):A72, Abstract No. 265, 1996.
Huang et al., "Is Abnormal Expression of Mitochondrial Genes in Skeletal Muscle Genetically Determined?," Diabetologia 40(Supplemental 1):A 168, Abstract No. 657, 1997.
Kahn, "Insulin Action, Diabetogenes, and the Cause of Type II Diabetes," Diabetes 43:1066-1084, 1994.
Kennedy and Lyons, "Glycation, Oxidation, and Lipoxidation in the Development of Diabetic Complications," Metabolism 46(12):14-21, 1997.
Kruszynska et al., "Regulation of Skeletal Muscle Hexokinase II by Insulin in Nondiabetic and NIDDM Subjects," Diabetes 47:1107-1113, 1998.
Lee, "Yonchon Experineces: Epidemiolgical Search for the Diabetogenic Factors," in Proceedings of the Course (The First Asia-Pacific Diabetes Epidemiology Training Course) at Young-In, Korea, Jul. 10-19, 1998, pp. 111-114.
Lee et al., "Decreased Mitochondrial DNA Content in Peripheral Blood Precedes the Development of Non-Insulin-Dependent Diabetes Mellitus," Diabetes Research and Clinical Practice 42:161-167, 1998.
Lee et al., "Peripheral Blood Mitochondrial DNA Contents Can Predict the Development of Diabetes," Diabetes 46(Supplement 1):175A, Abstract No. 0673, 1997.
Liang et al., "Increased Prevalence of Mitochondrial DNA Deletions in Skeletal Muscle of Older Individuals With Impaired Glucose Tolerance," Diabetes 46:920-923, 1997.
Lightowlers et al., "Mammalian Mitochondrial Genetics: Heredity, Heteroplasmy And Disease," TIG 13(11):450-455, 1997.
Liu and Roth, "Binding of SH2 Containing Proteins to the Insulin Receptor: A New Way for Modulating Insulin Signalling," Molecular Cellular Biochemistry 182:73-78, 1998.
Lopez et al., "Numt, a Recent Transfer and Tandem Amplification of Mitochondrial DNA to the Nuclear Genome of the Domestic Cat," Journal Of Molecular Evolution 39:174-190, 1994.
Marchetti et al., "Apoptosis-Associated Derangement of Mitochondrial Function in Cells Lacking Mitochondrial DNA," Cancer Research 56:2033-2038, 1996.
Midaoui et al., "Effect of Physical Training on Mitochondrial Function in Skeletal Muscle of Normal and Diabetic Rats," Metabolism 45(7):810-816, 1996.
Miller et al., "Creation and Characterization of Mitochondrial DNA-Depleted Cell Lines with "Neuronal-Like" Properties," Journal of Neurochemistry 67:1897-1907, 1996.
Moley et al., "Hyperglycemia Induces Apoptosis in Pre-Implantation Embryos Through Cell Death Effector Pathways," Nature Medicine 4(12):1421-1424, 1998.
Moraes et al., "mtDNA Depletion With Variable Tissue Expression: A Novel Genetic Abnormality In Mitochondrial Disease," Am. J. Hum. Genet. 48:492-501, 1991.
Nakamura et al., "A Novel Homoplasmic Point Mutation at Mitochondrial DNA (mtDNA) Nucleotide 3308 in a Family with Atypical Diabetes Mellitus (ADM) of African Americans (AA)," Diabetes 46(Supplement 1):175A, Abstract No. 0673, 1997.
Parfait et al., "Coamplification Of Nuclear Pseudogenes And Assessment Of Heteroplasmy Of Mitochondrial DNA Mutations," Biochemical And Biophysical Research Communications 247:57-59, 1998.
Parker, Jr. and Parks, "Abnormalities of the Electron Transport Chain in Idiopathic Parkinson's Disease," Ann. Neurol. 26:719-723, 1989.
Schwerzmann et al., "Molecular Architecture of the Inner Membrane of Mitochondria from Rat Liver: A Combined Biochemical and Sterological Study," The Journal Of Cell Biology 102:97-103, 1986.
Serradas et al., "Mitochondrial Deoxyribonucleic Acid Content Is Specifically Decreased in Adult, But Not Fetal, Pancreatic Islets of the Goto-Kakizaki Rat, a Genetic Model of Noninsulin-Dependent Diabetes," Endocrinology 136(12):5623-5631, 1995.
Simoneau and Kelley,"Altered Glycolytic and Oxidative Capacities of Skeletal Muscle Contribute to Insulin Resistance in NIDDM," J. Appl. Physiol. 83(1):166-171, 1997.
Soejima et al., "Mitochondrial DNA Is Required for Regulation of Glucose-stimulated Insulin Secretion in a Mouse Pancreatic Beta Cell Line, MIN6," The Journal of Biological Chemistry 271(42):26194-26199, 1996.
Spiegelman, "PPAR-.gamma.: Adipogenic Regulator and Thiazolidinedione Receptor," Diabetes 47:507-514, 1998.
Tatuch et al., "The 8993 mtDNA Mutation: Heteroplasmy And Clinical Presentation In Three Families," Eur. J. Hum. Genet. 2(1):35-43, 1994.
The Expert Committee On The Diagnosis And Classification Of Diabetes Mellitus, "Report of the Exert Committee on the Diagnosis and Classification of Diabetes Mellitus," Diabetes Care 22(Supplement 1):S5-S19, 1999.
Traverso et al., "Immunological Evidence for Increased Oxidative Stress in Diabetic Rats," Diabetologia 41:265-270, 1998.
Van den Bogert et al., "Regulation Of The Expression Of Mitochondrial Proteins: Relationship Between mtDNA Copy Number And Cytochrome-c Oxidase Activity In Human Cells And Tissues," Biochimica et Biophysica Acta 1144:177-183, 1993.
Velazquez et al., "Relation of Lipid Peroxides to Macrovascular Disease in Type 2 Diabetes," Diabetic Medicine 8:752-758, 1991.
Vesterga

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Indicators of altered mitochondrial function in predictive metho does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indicators of altered mitochondrial function in predictive metho, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indicators of altered mitochondrial function in predictive metho will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2049930

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.